Article Details
Retrieved on: 2024-04-16 22:45:53
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Unlike injectable anti-CGRP monoclonal antibodies that have been approved for migraine prevention -- erenumab (Aimovig), fremanezumab (Ajovy) ...
Article found on: www.medpagetoday.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here